Oramed Pharmaceuticals (Israel) Price Prediction and Hype Density Breakdown

ORMP -- Israel Stock  

null 1,625  69.00  4.43%

We analyze noise-free headlines and recent hype associated with Oramed Pharmaceuticals which may create opportunities for some arbitrage if properly timed. With Oramed Pharmaceuticals hype-based prediction module you can estimate the value of Oramed Pharmaceuticals from the prospective of Oramed Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Oramed Pharmaceuticals over a specific investment horizon. Additionally take a look at Your Equity Center.
Horizon     30 Days    Login   to change

Oramed Pharmaceuticals After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

Oramed Pharmaceuticals Estimiated After-Hype Price Volatility

December 11, 2018
Current Value
After-hype Price
Target Odds
Oramed Pharmaceuticals is Unknown risk asset. Analysis and calculation of next after-hype price of Oramed Pharmaceuticals is based on 2 months time horizon.

Oramed Pharmaceuticals Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.00% 0.00% 0.00%  0.00% 1 Events / Month4 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Oramed Pharmaceuticals Hype Timeline

Oramed Pharmaceuticals is now traded for 1,625on Tel Aviv Stock Exchange of Israel. This company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Oramed Pharmaceuticals is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is now at 0.0%. The volatility of relative hype elasticity to Oramed Pharmaceuticals is about 0.0%%. The volatility of related hype on Oramed Pharmaceuticals is about 0.0% with expected price after next announcement by competition of 1625.0. The company recorded loss per share of 0.88. Oramed Pharmaceuticals had not issued any dividends in recent years. Assuming 30 trading days horizon, the next anticipated press release will be very soon.
Additionally take a look at Your Equity Center.

Oramed Pharmaceuticals Related Hype Analysis

At Risk
Oil Refineries Ltd 4.70 7 per month 0.00  0.0482  2.63 (2.85)  7.03 
Bank Leumi le Israel B M 0.00 0 per month 1.14  0.19  1.80 (1.65)  5.45 
Perrigo Company plc 30.00 4 per month 0.00 (0.06)  3.35 (3.31)  14.43 
Israel Chemicals Ltd(12.00) 1 per month 2.54  0.13  3.78 (4.28)  10.61 
NICE Ltd(440.00) 5 per month 1.77  0.13  2.64 (2.90)  7.15 
Azrieli Group Ltd(150.00) 1 per month 1.09  0.15  1.88 (1.88)  6.68 
Elbit Systems Ltd 600.00 4 per month 0.00  0.08  3.18 (3.41)  8.84 
Mizrahi Tefahot Bank Ltd(11.00) 3 per month 1.02  0.21  1.98 (1.90)  4.27 
Israel Discount Bank Limited 1.00 2 per month 0.00  0.07  2.44 (3.01)  6.98 
Delek Drilling Limited Partnership(14.00) 1 per month 1.39  0.15  3.06 (2.79)  7.77 

Latest Stories

Recently Published Macroaxis Stories

Investors are also interested in

Purchased over 50 shares
Active few hours ago
Purchased over 20 shares
Active few hours ago
Purchased over 50 shares
Active few hours ago
Additionally take a look at Your Equity Center. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com